In contrast, gene expression studies in prostate cancer have shown that decreased expression of Meis1 is correlated with poor prognosis, suggesting that it may have tumor suppression activity in prostate cancer development [18]. This evidence concerns the gene MEIS1 and prostate carcinoma.